Children and adults with Prader-Willi syndrome who previously received once-daily diazoxide choline extended-release tablets ...
Pharmas will need to provide their latest stance on the Most Favored Nation drug pricing plans, while biotech finally gets a ...
InvestorsHub on MSN
Aquestive shares slide after FDA flags issues in Anaphylm filing
Aquestive Therapeutics (NASDAQ:AQST) saw its shares plunge about 40% on Friday after the company said the U.S. Food and Drug ...
Qure N.V. (NASDAQ:QURE) surged around 15% in early trading on Friday after the company said it has secured a Type A meeting ...
Each week, our team shares the latest recall alerts from sources such as the U.S. Food & Drug Administration (FDA), the U.S.
Given the FDA’s decision to initiate the removal of boxed warning labels from hormone therapy products, it may be prescribed ...
Marks a world-first as Regentis uses MOCART, a quantitative standard to measure regeneration of cartilage in a clinical ...
Crofelemer has been granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) and the European Medicines ...
Silicone’s composition gives it a synthetic polymer structure with a silicon-oxygen backbone, making it more resistant to ...
A successful Phase 3 trial and a public offeringof stock boosted prospects for this company to receive approval for an ...
The Ambriola Company issued a recall for its pecorino Romano cheese products in November over a potential listeria ...
MoonLake regains momentum after the FDA Type B meeting allows BLA submission for sonelokimab in HS without additional trials.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results